ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma.

Hong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.